Delivery Order SPE2DB24D3013-SPE2DB25FFPGW
- Not listed
- The Defense Logistics Agency awarded a $4,988.73 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed price order, with an ultimate completion date of July 15, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a non-competitive, non-set-aside award issued as a child order under AmerisourceBergen's larger contract vehicle with the DLA. This delivery order falls...
- The Defense Logistics Agency awarded a $5,394.86 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with a completion date of August 5, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the company's Corporate Office location in...
- The Defense Logistics Agency awarded a $20,352.45 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens. This firm fixed-price contract, which represents a child award under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by August 21, 2025. The award was competitively awarded with no set-aside designation, reflecting the company's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens valued at $4,911.97 on August 25, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle extending through December 2026. The delivery order is set to be completed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens in 0.5 ml quantities, with a ceiling value of $1,381.59. This competitively awarded, firm fixed-price delivery order is set to be completed by July 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-unit pharmaceutical procurement supporting military and...
- The Defense Logistics Agency awarded a $4,707.26 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract, which is structured as a firm fixed price delivery order with no set-aside designation, calls for completion by September 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement under AmerisourceBergen's existing pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,307.85 on July 15, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens. This firm fixed price, non-set-aside contract is scheduled for completion by July 16, 2025, with performance originating from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $4,504.50. This is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pens with a ceiling value of $2,503.89. This is a firm fixed-price delivery order with no set-aside designation, to be completed by August 5, 2025, and performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $4,281.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 21, 2025, with completion expected by July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical product will be delivered to...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPGWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,090.45 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pens. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is issued under AmerisourceBergen's prime IDC with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The parent contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and vaccines. AmerisourceBergen's substantial federal procurement portfolio demonstrates its critical role as a pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible contract vehicles designed to meet diverse medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/12/25 |